DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
Author:
Funder
Plan Propio de Investigacion, University of Granada
Publisher
Elsevier BV
Subject
Artificial Intelligence,Medicine (miscellaneous)
Reference61 articles.
1. Exploiting drug–disease relationships for computational drug repositioning;Dudley;Brief Bioinform,2011
2. Drug repositioning: identifying and developing new uses for existing drugs;Ashburn;Nat Rev Drug Discov,2004
3. Drug repositioning for orphan diseases;Sardana;Brief Bioinform,2011
4. The year's new drugs & biologics-2009.;Graul;Drug News Perspect,2010
5. The benefits of drug repositioning;Persidis;Drug Discov,2011
Cited by 170 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery;Archives of Biochemistry and Biophysics;2024-11
2. Computational drug repositioning with attention walking;Scientific Reports;2024-05-02
3. A review of deep learning algorithms for modeling drug interactions;Multimedia Systems;2024-04-14
4. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods;Briefings in Bioinformatics;2024-03-27
5. SADR: Self-Supervised Graph Learning With Adaptive Denoising for Drug Repositioning;IEEE/ACM Transactions on Computational Biology and Bioinformatics;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3